Naproxen

Aleve® Speaks The Painful Truth, Encouraging Consumers to Explore Their Pain Management Options

Retrieved on: 
星期一, 三月 25, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240325938118/en/
    Aleve launches "The Painful Truth" campaign with Mothers Against Prescription Drug Abuse (MAPDA) and National Consumers League (NCL).
  • (Photo: Business Wire)
    While opioid dispensing rates in the U.S. are slowly ticking down, they remain elevated compared with rates in other countries.
  • “The Painful Truth” campaign launches with a three-minute film featuring real pain sufferers who are at crossroads in their pain relief journeys and seeking guidance.
  • At this critical juncture in their care, the patients are encouraged to consider different pain relief options.

New Practice Guideline Co-Led by Penn Dental Medicine Details Dental Pain Management Strategies

Retrieved on: 
星期三, 三月 13, 2024

PHILADELPHIA, March 13, 2024 /PRNewswire/ -- A new clinical practice guideline for managing acute dental pain in adolescents and adults has been released, recommending nonsteroidal anti-inflammatory drugs (NSAIDs) taken alone or with acetaminophen as first-line treatments for managing short-term dental pain.

Key Points: 
  • PHILADELPHIA, March 13, 2024 /PRNewswire/ -- A new clinical practice guideline for managing acute dental pain in adolescents and adults has been released, recommending nonsteroidal anti-inflammatory drugs (NSAIDs) taken alone or with acetaminophen as first-line treatments for managing short-term dental pain.
  • The guideline was developed by Penn Dental Medicine's Center for Integrative Global Oral Health (CIGOH) , the American Dental Association (ADA), and the University of Pittsburgh School of Dental Medicine.
  • Dr. Alonso Carrasco-Labra, Associate Professor and Director of the Cochrane Oral Health Collaborating Center at Penn Dental Medicine, and Olivia Urquhart, an epidemiologist and instructor within CIGOH, co-led its development.
  • This is the second of two guidelines on acute dental pain management from this research team.

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Retrieved on: 
星期三, 一月 24, 2024

SAN DIEGO, Jan. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (the "FDA") has approved its supplemental New Drug Application ("NDA") for ZYNRELEF® (bupivacaine and meloxicam) extended-release solution to expand the indication for soft tissue and orthopedic surgical procedures including foot and ankle, and other procedures in which direct exposure to articular cartilage is avoided. ZYNRELEF was previously approved for foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures in adults.

Key Points: 
  • ZYNRELEF was previously approved for foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures in adults.
  • This expanded indication for ZYNRELEF will now cover an estimated 13 million procedures annually, an estimated increase of 86% over prior indicated procedures.
  • To obtain this labeling expansion, Heron successfully conducted studies for cesarean section, spinal surgery, augmentation mammoplasty, and total shoulder arthroplasty.
  • The most common side effects of ZYNRELEF are soft tissue procedures: vomiting and orthopedic procedures: constipation and headache.

Axine to Showcase Innovative Electrochemical Oxidation Technology at WEFTEC 2023

Retrieved on: 
星期五, 九月 29, 2023

Axine, a leader in advanced wastewater treatment solutions, is proud to announce its participation in WEFTEC 2023, the Water Environment Federation's Annual Technical Exhibition and Conference.

Key Points: 
  • Axine, a leader in advanced wastewater treatment solutions, is proud to announce its participation in WEFTEC 2023, the Water Environment Federation's Annual Technical Exhibition and Conference.
  • At WEFTEC 2023, Axine will showcase its innovative electrochemical oxidation (EOx) technology, specifically designed to address critical wastewater challenges, including the removal of per- and polyfluoroalkyl substances (PFAS) and emerging contaminants.
  • This advanced technology offers efficient, sustainable solutions for wastewater management, significantly contributing to a cleaner and safer environment.
  • For more information about Axine and its innovative EOx technology, visit www.axinewater.com .

MSG+ Provides New York Area NHL & NBA Fans More Ways to Watch Their Favorite Teams as NHL and NBA Seasons Begin

Retrieved on: 
星期二, 九月 19, 2023

NEW YORK, Sept. 19, 2023 /PRNewswire/ -- With the start of the 2023-24 NHL and NBA seasons around the corner, MSG Networks announced that MSG+, its new state-of-the art streaming product, will provide New York area NHL and NBA fans more ways than ever to watch their favorite teams. 

Key Points: 
  • NEW YORK, Sept. 19, 2023 /PRNewswire/ -- With the start of the 2023-24 NHL and NBA seasons around the corner, MSG Networks announced that MSG+, its new state-of-the art streaming product, will provide New York area NHL and NBA fans more ways than ever to watch their favorite teams.
  • MSG Networks also announced that the pharmaceutical company Bayer and the Aleve brand at Bayer will serve as the presenting sponsor for MSG+.
  • Bayer has been a thought leader in sports marketing and brand activation and will be presented throughout the MSG+ streaming service.
  • "This is an exciting time for MSG Networks and fans of our teams," said Andrea Greenberg, MSG Networks President and CEO.

One in Four American Adults Would Rather Not Know They Have Cancer

Retrieved on: 
星期一, 八月 21, 2023

As part of this commitment, Bayer has partnered with organizations like Zero Prostate Cancer , Target Cancer Foundation and Prostate Cancer Foundation to raise awareness and help individuals understand the resources available to them and their risks for specific disease.

Key Points: 
  • As part of this commitment, Bayer has partnered with organizations like Zero Prostate Cancer , Target Cancer Foundation and Prostate Cancer Foundation to raise awareness and help individuals understand the resources available to them and their risks for specific disease.
  • This survey was conducted online within the United States by The Harris Poll on behalf of Bayer from June 6-8, 2023, among 2,079 U.S. adults ages 18+.
  • For this study, the total sample data is accurate to within +/- 2.8 percentage points using a 95% confidence level.
  • For complete survey methodology, including weighting variables and subgroup sample sizes, please contact Nicole Hayes.

Bayer Donates $500K to Support Maui Community After Devastating Fires

Retrieved on: 
星期三, 八月 16, 2023

In the aftermath of the devastating fires that have affected the Maui community, Bayer stands in solidarity with those impacted and offers heartfelt condolences for the losses endured.

Key Points: 
  • In the aftermath of the devastating fires that have affected the Maui community, Bayer stands in solidarity with those impacted and offers heartfelt condolences for the losses endured.
  • With roots spanning more than 50 years in Maui County, Bayer is firmly committed to providing immediate relief and sustained support for recovery and rebuilding.
  • "We are grateful to be a part of the Maui community and are fully committed to providing support during this unprecedented time," stated Alan Takemoto, Government Affairs Lead, Bayer Hawaii.
  • As the journey toward recovery continues, Bayer remains dedicated to standing by the Maui community for years to come.

Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs

Retrieved on: 
星期二, 八月 8, 2023

Golden, Colorado, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) ("Panacea” or the "Company"), today announced the launch of their shift to an everyday low price pricing model for their full line of CBD products for pets and people. Panacea Life CBD products are regarded as some of the highest quality CBD products on the market due to their unique seed-to-sale approach that allows for premier quality control and opportunities to innovate distinct ingredient formulations that enhance and ensure maximum efficacy.

Key Points: 
  • Golden, Colorado, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) ("Panacea” or the "Company"), today announced the launch of their shift to an everyday low price pricing model for their full line of CBD products for pets and people.
  • Panacea Life CBD products are regarded as some of the highest quality CBD products on the market due to their unique seed-to-sale approach that allows for premier quality control and opportunities to innovate distinct ingredient formulations that enhance and ensure maximum efficacy.
  • One of the Company’s goals is to provide products that are just as effective and priced near common over-the-counter drugs like ibuprofen, aspirin or naproxen.
  • Launching their pricing changes on National CBD Day, August 8th, is ideal to bring CBD to the forefront of natural health products – a move that many suspect will be well received.

CHOP Researchers Reveal How NSAIDs Worsen C. difficile Infections

Retrieved on: 
星期三, 七月 19, 2023

PHILADELPHIA, July 19, 2023 /PRNewswire/ -- Why do nonsteroidal anti-inflammatory drugs (NSAIDs) exacerbate gastrointestinal infections by Clostridioides difficile, the leading cause of antibiotic-associated diarrhea worldwide? In a new paper published in Science Advances, researchers at Children's Hospital of Philadelphia (CHOP) have begun to answer that question, showing that NSAIDs disrupt the mitochondria of cells lining the colon, sensitizing them to damage by pathogenic toxins.

Key Points: 
  • However, researchers still know very little about how these factors impact the course of C. difficile infection.
  • Prior studies have shown that NSAIDs like indomethacin, aspirin, and naproxen negatively affect the gut, both in patients with C. difficile infection and other conditions like inflammatory bowel disease (IBD).
  • The researchers observed that both indomethacin and a C. difficile toxins increased epithelial cell barrier permeability and inflammatory cell death.
  • Surprisingly, the researchers found that NSAIDs exacerbate C. difficile infection independent of COX inhibition and instead through off-target effects on mitochondria.

Watch out for dangerous combinations of over-the-counter cold medicine and prescription drugs – two pharmacoepidemiology experts explain the risks

Retrieved on: 
星期五, 四月 21, 2023

When colds, flus and allergies hit, many people automatically turn to over-the-counter medications to push through and treat their symptoms.

Key Points: 
  • When colds, flus and allergies hit, many people automatically turn to over-the-counter medications to push through and treat their symptoms.
  • Nearly 70% of adults in the U.S. use over-the-counter medications as a first-line response for treating cold and flu symptoms.
  • We are a pharmacoepidemiologist and pharmacist team and we investigate adherence to medications and potential harms of medications associated with drug-drug interactions.
  • Another study estimated that every year, 26,735 people went to the emergency room for adverse events related to over-the-counter cold and cough medications.

The dangers of mixing medications

    • Pharmacists and physicians are typically knowledgeable about potential drug interactions, so it is very important for patients to ask their health care providers which over-the-counter medications are safe for them to use.
    • It is important to read the package ingredients of over-the-counter medications closely to avoid duplication of doses.
    • Cold medications are typically made up of multiple ingredients, including pain relievers, nasal decongestants and cough suppressants or expectorants.
    • Combining these decongestants with monoaminooxidase inhibitors or tricyclic antidepressants could lead to very high blood pressure and heart rhythm problems.

Each person responds to drugs differently

    • As we age, our bodies begin to lose the ability to efficiently clear drugs, which increases the risk of adverse events and unintentional overdoses.
    • Some drugs can be dangerous for people who have particular health conditions.
    • In addition, since these drugs are associated with increased blood pressure, patients with hypertension, hyperthyroidism or heart disease should be careful when using them, or avoid them altogether.

Alternatives for children

    • The Food and Drug Administration and the Centers for Disease Control and Prevention do not recommend giving cold medications to children under age 4.
    • Because of a variety of factors, young children have a higher risk of accidental overdose and adverse events that could lead to death.
    • Research has shown that honey can be helpful for reducing cold and flu symptoms in children older than age 1.

Pregnancy best practices

    • Acetaminophen is the doctor-recommended over-the-counter medication for management of pain and fever at any stage of pregnancy.
    • Any other pain relievers or anti-inflammatory medicine such as ibuprofen, ketoprofen, naproxen and aspirin should not be taken during pregnancy without a doctor’s approval.
    • For symptoms such as nasal congestion during pregnancy, a decongestant called oxymetazoline in its intranasal form is the drug of choice.